{"nctId":"NCT03316378","briefTitle":"Achilles Pain Block","startDateStruct":{"date":"2016-01-28","type":"ACTUAL"},"conditions":["Achilles Tendon Pain"],"count":46,"armGroups":[{"label":"Group with Achilles Tendinopathy","type":"EXPERIMENTAL","interventionNames":["Drug: Ropivacaine injection"]},{"label":"Group without Achilles Tendinopathy","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Ropivacaine injection","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"For patients with AT\n\nInclusion Criteria:\n\n\\- Clinical diagnosis of chronic (\\>3 months) AT, consisting of pain with pressure at the achilles tendon and report of pain that is aggravated by physical activity\n\nExclusion Criteria:\n\n* History of foot or ankle surgery, bilateral lateral epicondyle tendinopathy\n* Comorbidity that would be aggravated by placing hand in water (Raynaud's, thoracic outlet syndrome)\n* Comorbidity (e.g. stroke, neurological disorder) that limits ability to participate in exercise\n* Comorbidity (e.g. rheumatic disease, fibromyalgia) that contributes to pain with activity\n* Peripheral neuropathy\n* Previous adverse response to a local anesthetic injection\n* Are pregnant\n* Are a ballroom dancer\n\nFor control participants\n\nInclusion Criteria:\n\n\\- Sex, Age and BMI-matched to participant with AT\n\nExclusion Criteria:\n\n* No history of tendinopathy\n* No condition that limited activity in the past 6 months\n* History of foot or ankle surgery, bilateral lateral epicondyle tendinopathy\n* Comorbidity that would be aggravated by placing hand in water (Raynaud's, thoracic outlet syndrome)\n* Comorbidity (e.g. stroke, neurological disorder) that limits ability to participate in exercise\n* Comorbidity (e.g. rheumatic disease, fibromyalgia) that contributes to pain with activity\n* Peripheral neuropathy\n* Are pregnant\n* Are a ballroom dancer","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Central Sensitization","description":"Pressure pain threshold (PPT) at heel on contralateral side. A pressure algometer (Somedic, Farsta, Sweden) was applied perpendicular to the skin at a rate of 50 kilopascal/s with a 1cm2 tip. The participants pressed a button when the sensation of pressure first became painful (1/10 on NPRS). The mean of 3 trials per area represented the PPT.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"463.5","spread":null},{"groupId":"OG001","value":"383.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"425.7","spread":null},{"groupId":"OG001","value":"358.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Pain Psychology","description":"Tampa Scale of Kinesiophobia (TSK, score range 17 to 68). A decrease in TSK would indicate a decrease in fear of injury (and/or re-injury)","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37.2","spread":null},{"groupId":"OG001","value":"29.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.9","spread":null},{"groupId":"OG001","value":"28.7","spread":null}]}]}]},{"type":"PRIMARY","title":"Movement System","description":"Change in peak ankle power during the stance phase of gait during stair ascent, which will be assessed by syncing movement data from 3-dimensional motion analysis with ground reaction force data from a force plate. Peak positive ankle power reflects the ability of the plantar flexor muscles to concentrically generate speed and force at the ankle joint.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":null},{"groupId":"OG001","value":"3.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":null},{"groupId":"OG001","value":"2.8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":23},"commonTop":["Increased soreness"]}}}